June 20, 2013 / 5:18 AM / 4 years ago

Belgian heart drug firm Cardio3 launches IPO

BRUSSELS, June 20 (Reuters) - Belgian heart drug specialist Cardio3 BioSciences IPO-CARD.BR launched an initial public offering in Brussels and Paris on Thursday, valuing its shares at between 16.65 euros and 19.00 euros each.

It said two long-term investors, Wallonia regional investment group SRIW and PMV, a Flemish investment organisation, had guaranteed a commitment of 13.95 million euros at any price.

The offer period will run from June 21 to July 3. (Reporting By Ben Deighton)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below